Publicaciones en colaboración con investigadores/as de Ghent University Hospital (1)

2024

  1. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)

    European urology oncology, Vol. 7, Núm. 5, pp. 1051-1060